Target intelligence / Profile preview

Cellular signaling and survival pathways

Molecular classification
Other
01

Overview

Cellular signaling and survival pathways represent the integrated networks of biochemical reactions, such as the PI3K/AKT/mTOR and MAPK/ERK cascades, that translate extracellular stimuli into specific cellular responses like growth, differentiation, and survival (Source: NIH, National Cancer Institute). These pathways are critical for maintaining cellular homeostasis and ensuring that cells only proliferate or survive when appropriate environmental cues are present (Source: Nature Reviews Molecular Cell Biology). In many diseases, particularly oncology, these pathways are frequently hijacked or dysregulated through mutations or overexpression, leading to uncontrolled cell division and resistance to programmed cell death (Source: StatPearls). While these pathways contain numerous high-value therapeutic targets, the term itself refers to a broad biological category rather than a single protein or receptor (Source: PubMed). Consequently, pharmacological intervention focuses on specific components within these networks to restore normal signaling or selectively eliminate diseased cells, though such strategies must account for the essential role these pathways play in healthy tissue (Source: Journal of Clinical Investigation).

Other names
Cell survival signalingIntracellular signaling cascadesSignal transduction pathwaysSurvival signaling networks
02

Mechanism of action

Drugs targeting these pathways typically function by inhibiting specific enzymatic nodes (e.g., kinases like PI3K, AKT, or MEK), blocking cell surface receptors (e.g., EGFR), or modulating downstream effectors to arrest growth or induce apoptosis in aberrant cells (Source: PubMed, Nature Reviews Drug Discovery).

03

Biological functions

Signal transductionCell survivalApoptosisCell proliferationGrowth regulationMetabolism
04

Disease associations

CancerNeurodegenerative diseaseInflammationAutoimmune diseaseCardiovascular disease
05

Safety considerations

Systemic toxicity due to inhibition of essential physiological signalingDevelopment of acquired resistance through bypass signalingOff-target effectsNarrow therapeutic indexHyperglycemia or immunosuppression (pathway-dependent)
06

Interacting drugs

5 more in the full profile.

07

Biomarkers

Phospho-AKT levelsERK phosphorylation statusPTEN expression/mutationBRAF V600E mutationCaspase-3 activationKi-67 proliferation index

Beyond the preview

Go deeper on Cellular signaling and survival pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular signaling and survival pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call